Chesterbrook, PA, March 03, 2026 (GLOBE NEWSWIRE) -- Persevere Therapeutics, Inc. ("Persevere"), a Delaware-incorporated, clinical-stage oncology biotechnology company, today announced its official ...
Chesterbrook, PA, Aug. 31, 2026 (GLOBE NEWSWIRE) -- (“Persevere”), a clinical-stage oncology company developing misetionamide — a first-in-class inhibitor of MYC, historically viewed as undruggable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results